By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biocryst Pharmaceuticals 

2190 Parkway Lake Drive

Birmingham  Alabama  35244  U.S.A.
Phone: 205-444-4600 Fax:




Affinimark Technologies Inc. 

Company News
Biocryst (BCRX) Announces Initiation Of The Apex-1 Clinical Trial Of BCX7353 For Hereditary Angioedema 8/11/2016 11:00:56 AM
Biocryst (BCRX) Reports Second Quarter 2016 Financial Results 8/4/2016 11:27:49 AM
Biocryst (BCRX) To Announce Second Quarter 2016 Financial Results August 4 7/21/2016 8:05:20 AM
Biocryst (BCRX) Receives Additional NIAID Funding To Advance Development Of BCX4430 To Treat Hemorrhagic Fever Virus Diseases 7/5/2016 10:42:23 AM
Biocryst (BCRX) To Present At Two Upcoming Investor Conferences 5/26/2016 8:12:46 AM
Top 5 Biotech Winners and Losers of Q1 2016 3/31/2016 7:08:32 AM
Biocryst (BCRX)'s Zika Drug Shows Promise In Mice 3/7/2016 6:51:14 AM
Stock Plunges as Biocryst (BCRX)'s Angioedema Drug Flunks Phase II Study 2/8/2016 6:29:26 AM
Biocryst Pharmaceuticals (BCRX) To Present At Two Upcoming Investor Conferences 11/24/2015 7:41:46 AM
Biocryst Pharmaceuticals (BCRX) Reports Third Quarter 2015 Financial Results 11/5/2015 10:26:16 AM